Dextech Financial Statements From 2010 to 2026

LQ0 Stock   1.00  0.02  1.96%   
Dextech Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Dextech Medical's valuation are provided below:
Profit Margin
(1.43)
Market Capitalization
15.1 M
Earnings Share
(0.02)
Quarterly Revenue Growth
0.414
There are over thirty available fundamental signals for Dextech Medical AB, which can be analyzed over time and compared to other ratios. Active traders should verify all of Dextech Medical AB prevailing fundamental drivers against the trend between 2010 and 2026 to make sure the company can sustain itself down the road.
Check Dextech Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dextech Medical's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 458.2 K or Interest Income of 458.2 K, as well as many indicators such as . Dextech financial statements analysis is a perfect complement when working with Dextech Medical Valuation or Volatility modules.
  
This module can also supplement various Dextech Medical Technical models . Check out the analysis of Dextech Medical Correlation against competitors.

Dextech Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets26.1 M22.6 M36.1 M
Slightly volatile
Other Current Liabilities16.7 K20.8 K25.3 K
Slightly volatile
Total Current Liabilities549.4 K303.2 K672.3 K
Slightly volatile
Total Stockholder Equity25.5 M22.3 M35.5 M
Slightly volatile
Accounts Payable161.5 K116.9 K227.9 K
Slightly volatile
Cash18.9 M13.2 M30.4 M
Slightly volatile
Non Current Assets Total9.2 M11.4 M5.5 M
Slightly volatile
Common Stock Shares Outstanding14.8 M16.6 M18.2 M
Slightly volatile
Total Liabilities549.4 K303.2 K672.3 K
Slightly volatile
Net Invested Capital25.5 M22.3 M35.5 M
Slightly volatile
Total Current Assets19.3 M13.7 M30.9 M
Slightly volatile
Capital Stock665.5 K748.7 K817.2 K
Slightly volatile
Net Working Capital18.8 M13.4 M30.3 M
Slightly volatile
Intangible Assets9.2 M11.4 M5.5 M
Slightly volatile
Net Receivables378.4 K425.7 K464.7 K
Slightly volatile

Dextech Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative3.7 M4.2 M4.5 M
Slightly volatile
Gross Profit4.1 M2.9 M3.6 M
Slightly volatile
Total Operating Expenses5.8 M6.1 M5.4 M
Slightly volatile
Reconciled Depreciation3.8 M4.8 M3.3 M
Slightly volatile

Dextech Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow22.9 M21.9 M9.8 M
Slightly volatile
Depreciation3.8 M4.8 M3.3 M
Slightly volatile
Capital Expenditures4.1 M2.9 M3.6 M
Slightly volatile
End Period Cash Flow18.9 M13.2 M30.4 M
Slightly volatile

About Dextech Medical Financial Statements

Dextech Medical stakeholders use historical fundamental indicators, such as Dextech Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Dextech Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Dextech Medical's assets and liabilities are reflected in the revenues and expenses on Dextech Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Dextech Medical AB. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue-3.7 M-3.9 M

Currently Active Assets on Macroaxis

Other Information on Investing in Dextech Stock

Dextech Medical financial ratios help investors to determine whether Dextech Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dextech with respect to the benefits of owning Dextech Medical security.